| BACKGROUND
The first laboratory-confirmed case of influenza A(H1N1)pdm09 was identified in the United States in April 2009. 1 The Longitudinal cohort studies measuring the change in antibody titers over time are an important adjunct to surveillance and assist in the estimation of the true infection burden. We followed a community cohort in a low-income urban area of Dhaka, Bangladesh, from the beginning of the pandemic in Bangladesh until after the first wave of illness. In this study, we report A(H1N1)pdm09 antibody levels before and after the first wave of the pandemic following the Reporting
Of Seroepidemiologic Studies for Influenza (ROSES-I) guidelines
provided by the Consortium for the Standardization of Influenza Seroepidemiology (CONCISE). 6 These data provide insight into the burden of A(H1N1)pdm09 infections, including clinical and subclinical infection, and residual susceptibility after the first wave of the pandemic in Dhaka, Bangladesh.
| METHODS

| Ethics statement
Informed consent was obtained from all adults. For children aged 8-17 years, consent was obtained from both the child and their parents or guardians, while informed consent was obtained from the parents or guardians for children aged <8 years. The study was approved by both the institutional review boards at icddr,b and the U.S. Centers for Disease Control and Prevention (CDC). 
| Setting
| Laboratory analysis
We randomly selected ~20% of the paired sera from participants aged <60 years, while all sera from participants aged >60 years (N=71) were tested. We chose to include these sera samples in our study instead of the paired sera collected from 3048 individuals considering the resources that would be required for the laboratory analysis of all the samples. Random selection of the samples for laboratory testing likely did not introduce any selection bias because the study participants were similar to the overall surveillance population with respect to age and sex distribution (Table 1 ). Paired sera were tested by microneutraliza- sera of ten participants (~1% of total sera) having a titer of ≥20 by HI assay were not tested by MN assay due to insufficient volume, and thus, an HI titer of ≥20 would be sufficiently sensitive in detecting infection with A(H1N1)pdm09 among the participants aged <60 years. 9 Furthermore, in a previous study, 11% of confirmed cases in England did not have HI titer of ≥32 at baseline suggesting that a cutoff HI titer value of ≥40 could underestimate infection. 10 We also present baseline serology of both HI titer of ≥20 and MN titer of ≥40 because this combined titer provided the best balance of sensitivity and specificity for US individuals aged <60 years. 
| Clinical data of participants with serology results
Information on clinical illness was collected through weekly home visit questionnaires and project clinic visit documents (case report form and clinic visit sheets) for the participants with serology results, as previously described. 
| Data analysis
We calculated 95% CI for the proportions of baseline serology (titers of ≥20 and ≥40 by HI assay and a titer of ≥40 by MN assay) and proportions of seroconversion against A(H1N1)pdm09 virus antibodies using binomial distribution. We adjusted the proportion of seroconversions (by HI and MN assay) for household clustering using clustered sandwich estimator for variance-covariance matrix estimation. We considered symptomatic A(H1N1)pdm09 infection among the seroconverted participants if the symptoms developed 3 weeks or more prior to the collection of follow-up serum specimen. We estimated A(H1N1)pdm09 infection among Dhaka district population by applying the overall proportion of adjusted seroconversion observed among our study participants.
| RESULTS
Among 6600 households under surveillance for the drug study, 930
households were approached and asked to consent to the serology study; 220 members from 44 households refused to participate. We collected baseline serum specimens from 3647 individuals; 116 individuals refused to give a serum sample. We collected follow-up serum specimens from 3048 individuals; 198 participants refused to provide follow-up serum.
We tested 709 randomly selected paired sera from participants aged <60 years and 71 paired sera from participants aged >60 years.
Overall, 779/780 provided paired sera; one participant provided only a single serum at baseline. The age range of the participants was one month to 107 years. The highest proportion of participants was aged 18-39 years ( Table 1) . None of the participants had ever received any influenza vaccine.
| Serology against A(H1N1)pdm09 virus
At baseline, nine (1%) of 779 participants were seropositive. A similar proportion of participants had A(H1N1)pdm09 virus antibody titers ≥20 by HI assay and ≥40 by MN assay ( Table 2 ). The highest propor- (Table 3 ).
| Clinical profile of the participants
Clinical illness information from weekly household visits was available for 739 participants. However, 264 of 780 (34%) individuals with serology results had information on illness >3 weeks prior to collection of follow-up sera. Overall, 72% (191/264) of these participants reported a febrile or respiratory illness >3 weeks prior to collection of follow-up sera (Table 4) 
| Estimated A(H1N1)pdm09 infection among Dhaka population
Applying the overall adjusted proportion of seroconversion found among our study participants to the population of Dhaka, we esti- 
| DISCUSSION
Our study findings suggest that one in four immune-naïve persons reported by a recent meta-analysis, 13 but higher than the rates in Singapore (13%) and Hong Kong (14%) 14, 15 and lower than the USA (35%). 16 The highest proportion of A(H1N1)pdm09 virus infection occurred among school-aged children in our study, consistent with findings from these other studies. Older adults aged >40 had more infections than young adults or children <5 years. We found serologic evidence for infection among ~20% of those without symptoms;
however, most of these occurred among children aged <5 years.
These data help to understand the full burden of H1N1pdm09 infections in Bangladesh after the first wave of the pandemic.
Interestingly, we found a very low level of immunity to A(H1N1) pdm09 prior to the first wave of the pandemic, even among older adults. Even after evaluating different titer thresholds for a seropositivity definition (HI titer ≥20 or ≥40, or combined HI titer ≥20 and MN titer ≥40), the proportion of older adults with seropositivity at baseline was low but within the range reported from China. 17 It was substantially lower than in estimates of pre-pandemic UK, USA, and Australian populations. 10, 18, 19 Our study is unique in that we could follow a cohort longitudinally.
Most seroprevalence studies from the pandemic were cross-sectional and included different study populations in pre-and post-first pandemic wave samples. 20 Other strengths of our study were that we included all age groups. To our knowledge, no other published study has reported on all age groups at the start of the pandemic. Importantly, we also systematically collected clinical information on a subset of the surveyed population. Clinical data are generally not available when serosurveys use blood bank samples or residual laboratory sera. 20 There are several important limitations to our study. Although we started our study before A(H1N1)pdm09 virus spread to the general population in the country, it is possible that some of the baseline titers were due to recent A(H1N1)pdm09 infections among our study population; however, at the time of launching our survey, our ongoing surveillance systems had not detected such cases.
The survey was conducted in a single field site, and infection rates may have differed in other parts of the city and country; however, comparisons of influenza circulation in the site to those from the hospital network, which is nationwide, suggest that circulation patterns in this community are comparable. 8, 21 We may have missed some infections by relying only on serology. This could have disproportionately affected the very young and the elderly, resulting in an underestimation of infection in those age groups. Despite these limitations, the findings from this study provide insight into the propagation of a novel virus through a densely populated but immunologically naive population with a high background rate of seasonal influenza infection.
| CONCLUSION
Our study demonstrated that most of the study participants were susceptible to A(H1N1)pdm09 infection before the first wave of the pandemic and that even the majority of the elderly population lacked protective immunity from previous exposure to similar virus. About a quarter of the population was infected and the highest detected burden of infection occurred among the school-aged children during the first wave of the pandemic. Three-fourths of the population remained uninfected and susceptible at the end of the first pandemic wave.
